Drug Shortage Report for IRBESARTAN HCT

Last updated on 2021-02-12 History
Report ID 126600
Drug Identification Number 02385317
Brand name IRBESARTAN HCT
Common or Proper name IRBESARTAN HCT
Company Name SIVEM PHARMACEUTICALS ULC
Market Status MARKETED
Active Ingredient(s) IRBESARTAN HYDROCHLOROTHIAZIDE
Strength(s) 150MG 12.5MG
Dosage form(s) TABLET
Route of administration ORAL ORAL
Packaging size 100
ATC code C09DA
ATC description ANGIOTENSIN II ANTAGONISTS, COMBINATIONS
Reason for shortage Requirements related to complying with good manufacturing practices.
Anticipated start date
Actual start date 2020-10-12
Estimated end date Unknown
Actual end date 2020-11-30
Shortage status Resolved
Updated date 2021-02-12
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 4705 DOBRIN STREET
SAINT-LAURENT, QUEBEC
CANADA H4R 2P7
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v4 2021-02-12 French Compare
v3 2021-02-12 English Compare
v2 2020-10-16 French Compare
v1 2020-10-16 English Compare

Showing 1 to 4 of 4